Trial to Evaluate the Safety and Efficacy of Keppra After Conversion to Mono-therapy in Subjects With Partial Epilepsy

NCT00630357 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Epilepsy

Interventions

DRUG: Levetiracetam (Keppra)

Sponsor

UCB Pharma